Significant Wealth Partners’s AbbVie ABBV Stock Holding History

Significant Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.14M	Buy	8,485 +172	+2%	+$37K	2.31%	7
2026 Q1	$1.81M	Buy	8,313 +5,000	+151%	+$1.11M	2.23%	11
2025 Q4	$757K	Sell	3,313 -3,551	-52%	-$809K	0.84%	11
2025 Q3	$1.59M	Sell	6,864 -112	-2%	-$22.8K	0.78%	7
2025 Q2	$1.29M	Sell	6,976 -18	-0.3%	-$3.35K	0.64%	9
2025 Q1	$1.47M	Sell	6,994 -51	-0.7%	-$9.91K	0.75%	5
2024 Q4	$1.25M	Sell	7,045 -813	-10%	-$149K	0.65%	5
2024 Q3	$1.55M	Buy	7,858 +116	+1%	+$21.6K	0.8%	6
2024 Q2	$1.33M	Sell	7,742 -1,753	-18%	-$290K	0.75%	5
2024 Q1	$1.73M	Buy	9,495 +1,995	+27%	+$344K	1.13%	29
2023 Q4	$1.16M	Buy	+7,500	New	+$1.09M	0.85%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Significant Wealth Partners's ABBV Position: Q2 2026 in Review

Significant Wealth Partners increased its AbbVie (ABBV) stake by 2.1% in Q2 2026, buying an estimated $37K and bringing the position to 8,485 shares worth $2.14M. The position accounts for 2.31% of the portfolio, ranked #7.

Significant Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Significant Wealth Partners held 8,485 shares of AbbVie worth $2.14M as of Q2 2026.
Significant Wealth Partners bought 172 AbbVie shares in Q2 2026, an estimated $37K.
AbbVie made up 2.31% of Significant Wealth Partners's portfolio in Q2 2026, its #7 holding.
Significant Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Significant Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.